feed

view company updates

tools

perform investment research

network

join events & discussions

advisory

about us

Redeye Capital

Herantis Pharma: Comment on Directed Share Issue

Redeye comments on yesterday’s directed share issue of EUR 4 million.

FT

Fredrik Thor

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.